LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	121 Pages	Triton Market Research	July, 2021	TRTN16847406

Best Price Guarantee
Price	from $1,500
Length	121 Pages
Publisher	Triton Market Research
Published Date	July, 2021
SKU	TRTN16847406

LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028

MARKET OUTLOOK

Triton’s research report insinuates that the Latin American infertility testing and treatment market is estimated to grow at a CAGR of 9.71% during the period 2021-2028. Mexico, Brazil, and Rest of Latin America shape the market in this region.

In Mexico, the growing number of clinically advanced fertility centers is anticipated to predominantly support the growth of the studied market. For instance, earlier, INVO Bioscience announced its venture to operate as a fertility clinic in the country. Furthermore, the availability of technologically developed infertility treatment devices is expected further to enhance the demand for infertility treatments and devices. This will ultimately widen the scope and growth of the infertility testing and treatment market across Mexico in the near future.

On the other hand, Argentina’s infertility testing and treatment market is anticipated to advance at a rapid pace over the forecast period. The major factor supporting this growth is the rising infertility cases, owing to hormonal disorders and substance abuse. As per estimates, a significant amount of the country’s population suffers from PCOS and prostate cancer. Here, some of the treatments for prostate cancer can lead to a decrease in sperm count. This increases the demand for infertility treatments. Furthermore, Argentina emerged as the tourism hotspot for fertility treatment, owing to affordable IVF treatments and high medical services. Hence, as mentioned above, these factors are likely to increase the demand for infertility treatments, boosting the infertility testing and treatment market’s expansion within Argentina.

COMPETITIVE OUTLOOK

Some of the enterprises in the infertility testing and treatment market include Endo International Plc, Genea Ltd, Labotect GmbH, Cook Medical Inc, Progyny, Cooper Surgical, and Bangkok IVF Center.

1. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET - SUMMARY
2. INDUSTRY OUTLOOK: 2.1. KEY INSIGHTS; 2.1.1. GROWING DEMAND FOR LOW-COST PROCEDURES; 2.1.2. INCREASING ACCEPTANCE OF DONOR EGGS; 2.1.3. USE OF AI INCREASES THE SUCCESS OF IVF TREATMENT; 2.2. IMPACT OF COVID-19 ON INFERTILITY TESTING AND TREATMENT MARKET; 2.3. PORTER’S FIVE FORCES ANALYSIS; 2.3.1. THREAT OF NEW ENTRANTS; 2.3.2. THREAT OF SUBSTITUTE; 2.3.3. BARGAINING POWER OF SUPPLIERS; 2.3.4. BARGAINING POWER OF BUYERS; 2.3.5. THREAT OF COMPETITIVE RIVALRY; 2.4. KEY BUYING IMPACT ANALYSIS; 2.4.1. TREATMENT OPTIONS; 2.4.2. QUALITY OF MEDICAL PROCEDURES; 2.4.3. PRICE OF TREATMENTS; 2.4.4. SHIFT TOWARDS MEDICAL TOURISM; 2.4.5. REIMBURSEMENT; 2.5. MARKET ATTRACTIVENESS MATRIX; 2.6. INDUSTRY COMPONENTS; 2.6.1. RAW MATERIAL PROCUREMENT; 2.6.2. MANUFACTURING; 2.6.3. SUPPLY LOGISTICS; 2.6.4. DISTRIBUTION CHANNELS; 2.6.5. END-USERS; 2.7. VENDOR SCORECARD; 2.8. KEY MARKET STRATEGIES; 2.8.1. CONTRACTS & PARTNERSHIPS; 2.8.2. ACQUISITIONS & MERGERS; 2.8.3. NEW PRODUCT LAUNCHES; 2.9. MARKET DRIVERS; 2.9.1. GROWTH IN STRESS AND LIFESTYLE DISORDERS; 2.9.2. RISING TREND IN DEPLAYED MARRIAGES AND PREGNANCIES; 2.9.3. IMPROVEMENTS IN TREATMENTS; 2.9.4. GOVERNMENT SUPPORT; 2.10. MARKET CHALLENGES; 2.10.1. HIGH COST; 2.10.2. SOCIAL TABOO PERTAINING TO INFERTILITY; 2.10.3. RISKS ASSOCIATED WITH TREATMENTS; 2.11. MARKET OPPORTUNITIES; 2.11.1. TECHNOLOGY ADVANCEMENTS IN TIME-LAPSE TECHNOLOGY; 2.11.2. ADVANCES IN EMBRYO BIOPSY AND GENETIC SCREENING
3. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET – BY GENDER: 3.1. MALE; 3.1.1. MALE INFERTILITY TESTING; 3.1.1.1. DNA FRAGMENTATION; 3.1.1.2. OXIDATIVE STRESS ANALYSIS; 3.1.1.3. SPERM PENETRATION ASSAY; 3.1.1.4. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA); 3.1.1.5. SPERM AGGLUTINATION; 3.1.1.6. MICROSCOPIC EXAMINATION; 3.1.1.7. OTHERS; 3.1.2. MALE INFERTILITY TREATMENT; 3.1.2.1. MEDICATION; 3.1.2.2. ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY; 3.2. FEMALE; 3.2.1. FEMALE INFERTILITY TESTING; 3.2.1.1. OVULATION TESTING; 3.2.1.2. HYSTEROSALPINGOGRAPHY; 3.2.1.3. LAPAROSCOPY; 3.2.1.4. TRANSVAGINAL ULTRASOUND; 3.2.1.5. OVARIAN RESERVE TESTING; 3.2.1.6. HORMONAL LEVEL TESTING; 3.2.1.7. OTHERS; 3.2.2. FEMALE INFERTILITY TREATMENT; 3.2.2.1. IVF WITH ICSI; 3.2.2.2. IUI; 3.2.2.3. IVF WITHOUT ICSI; 3.2.2.4. SURROGACY; 3.2.2.5. THERS
4. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET - BY END-USER: 4.1. FERTILITY AND SURGICAL CENTERS; 4.2. HOSPITALS & RESEARCH LABORATORIES; 4.3. CRYOBANKS
5. LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET – REGIONAL OUTLOOK: 5.1. BRAZIL; 5.2. MEXICO; 5.3. REST OF LATIN AMERICA
6. COMPETITIVE LANDSCAPE: 6.1. ADORFEM; 6.2. BANGKOK IVF CENTER; 6.3. COOK MEDICAL INC; 6.4. COOPER SURGICAL; 6.5. CREATE FERTILITY CENTRE; 6.6. EMD GROUP (MERCK KGAA); 6.7. ENDO INTERNATIONAL PLC; 6.8. FERRING PHARMACEUTICALS; 6.9. HALOTECH DNA; 6.10. GENEA LTD; 6.11. FUJIFILM IRVINE SCIENTIFIC; 6.12. VITROLIFE AB; 6.13. LABOTECT GMBH; 6.14. OLYMPUS CORPORATION; 6.15. PROGYNY
7. METHODOLOGY & SCOPE: 7.1. RESEARCH SCOPE & DELIVERABLES; 7.2. SOURCES OF DATA; 7.3. RESEARCH METHODOLOGY; LIST OF TABLES; TABLE 1: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION); TABLE 2: MARKET ATTRACTIVENESS MATRIX; TABLE 3: VENDOR SCORECARD; TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS; TABLE 5: LIST OF ACQUISITIONS & MERGERS; TABLE 6: LIST OF NEW PRODUCT LAUNCHES; TABLE 7: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS; TABLE 8: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION); TABLE 9: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION); TABLE 10: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION); TABLE 11: PROS AND CONS OF DNA SHARING METHODS; TABLE 12: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION); TABLE 13: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION); TABLE 14: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION); TABLE 15: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION); TABLE 16: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION); TABLE 17: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION); LIST OF FIGURES; FIGURE 1: PORTER’S FIVE FORCES ANALYSIS; FIGURE 2: KEY BUYING IMPACT ANALYSIS; FIGURE 3: INDUSTRY COMPONENTS; FIGURE 4: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %); FIGURE 5: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION); FIGURE 6: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2020 & 2028 (IN %); FIGURE 7: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION); FIGURE 8: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2020 & 2028 (IN %); FIGURE 9: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION); FIGURE 10: CAUSES OF SPERM DNA FRAGMENTATION; FIGURE 11: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION); FIGURE 12: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION); FIGURE 13: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION); FIGURE 14: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION); FIGURE 15: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION); FIGURE 16: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION); FIGURE 17: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION); FIGURE 18: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2020 & 2028 (IN %); FIGURE 19: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION); FIGURE 20: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION); FIGURE 21: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION); FIGURE 22: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2020 & 2028 (IN %); FIGURE 23: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION); FIGURE 24: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2020 & 2028 (IN %); FIGURE 25: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION); FIGURE 26: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION); FIGURE 27: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION); FIGURE 28: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION); FIGURE 29: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION); FIGURE 30: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION); FIGURE 31: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION); FIGURE 32: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION); FIGURE 33: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2020 & 2028 (IN %); FIGURE 34: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION); FIGURE 35: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION); FIGURE 36: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION); FIGURE 37: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION); FIGURE 38: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION); FIGURE 39: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2020 & 2028 (IN %); FIGURE 40: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION); FIGURE 41: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY HOSPITALS & RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION); FIGURE 42: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION); FIGURE 43: LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %); FIGURE 44: BRAZIL INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION); FIGURE 45: MEXICO INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION); FIGURE 46: REST OF LATIN AMERICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)